BN Business News
Add your company to Business Communicator →

Business · 06/08/2003Updated: 10/17/2026 · 1 min read

FDA and NIAID Host Public Workshop on Febrile Neutropenia and Antifungal Combination Therapy

Summary

The FDA, in collaboration with NIAID, is hosting a public workshop to gather input from various stakeholders on the clinical trial design for treating febrile neutropenia and antifungal combination therapy, with the goal of informing drug development in this area.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →